Analysts See $0.84 EPS for Take-Two Interactive Software, Inc. (TTWO); Galmed Pharmaceuticals Limited Ord (GLMD) Shorts Increased By 17.06%

January 15, 2018 - By Peter Erickson

Analysts expect Take-Two Interactive Software, Inc. (NASDAQ:TTWO) to report $0.84 EPS on February, 6.They anticipate $0.13 EPS change or 18.31% from last quarter’s $0.71 EPS. TTWO’s profit would be $95.80M giving it 34.91 P/E if the $0.84 EPS is correct. After having $0.76 EPS previously, Take-Two Interactive Software, Inc.’s analysts see 10.53% EPS growth. The stock increased 0.27% or $0.32 during the last trading session, reaching $117.3. About 1.76 million shares traded. Take-Two Interactive Software, Inc. (NASDAQ:TTWO) has risen 81.23% since January 15, 2017 and is uptrending. It has outperformed by 64.53% the S&P500.

Galmed Pharmaceuticals Limited Ord (NASDAQ:GLMD) had an increase of 17.06% in short interest. GLMD’s SI was 29,500 shares in January as released by FINRA. Its up 17.06% from 25,200 shares previously. With 27,500 avg volume, 1 days are for Galmed Pharmaceuticals Limited Ord (NASDAQ:GLMD)’s short sellers to cover GLMD’s short positions. The SI to Galmed Pharmaceuticals Limited Ord’s float is 0.4%. The stock decreased 0.63% or $0.07 during the last trading session, reaching $11.07. About 34,068 shares traded. Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) has risen 0.41% since January 15, 2017 and is uptrending. It has underperformed by 16.29% the S&P500.

Since August 4, 2017, it had 0 insider purchases, and 4 sales for $7.68 million activity. $614,600 worth of Take-Two Interactive Software, Inc. (NASDAQ:TTWO) shares were sold by Dornemann Michael. Sheresky Michael sold $41,831 worth of stock or 465 shares. Shares for $4.39M were sold by ZELNICK STRAUSS on Friday, August 4. 30,000 shares valued at $2.63 million were sold by Goldstein Lainie on Friday, August 4.

Investors sentiment decreased to 1.18 in Q3 2017. Its down 0.10, from 1.28 in 2017Q2. It is negative, as 40 investors sold Take-Two Interactive Software, Inc. shares while 124 reduced holdings. 72 funds opened positions while 122 raised stakes. 100.22 million shares or 0.81% more from 99.42 million shares in 2017Q2 were reported. Janney Montgomery Scott Ltd Liability invested in 9,735 shares or 0.01% of the stock. Aperio Group Limited Liability Company, a California-based fund reported 25,780 shares. Ardsley Advisory Prtnrs reported 5,000 shares. Columbus Circle Investors accumulated 781,894 shares. Mark Asset Management Corporation has invested 1.64% of its portfolio in Take-Two Interactive Software, Inc. (NASDAQ:TTWO). Discovery Capital Limited Com Ct stated it has 1.01M shares. Victory Cap Mgmt, Ohio-based fund reported 359,636 shares. Conatus Cap Management Ltd Partnership owns 1.85% invested in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) for 150,142 shares. Virginia Retirement Et Al holds 19,500 shares. Wealth Enhancement Advisory Services Llc has invested 0.08% in Take-Two Interactive Software, Inc. (NASDAQ:TTWO). Hbk Invests Ltd Partnership has 0.06% invested in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) for 79,268 shares. Gilder Gagnon Howe And Co Ltd Limited Liability Company has 491,757 shares for 0.71% of their portfolio. Canada Pension Plan Board holds 0.07% or 345,400 shares. Guggenheim Capital Ltd Llc invested 0.05% in Take-Two Interactive Software, Inc. (NASDAQ:TTWO). Sg Americas Securities Limited Liability Corporation owns 0.01% invested in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) for 13,350 shares.

Among 19 analysts covering Take-Two Interactive Software (NASDAQ:TTWO), 15 have Buy rating, 1 Sell and 3 Hold. Therefore 79% are positive. Take-Two Interactive Software had 68 analyst reports since July 28, 2015 according to SRatingsIntel. The stock has “Buy” rating by Buckingham Research on Wednesday, November 8. The stock of Take-Two Interactive Software, Inc. (NASDAQ:TTWO) earned “Hold” rating by Robert W. Baird on Thursday, August 3. Robert W. Baird maintained Take-Two Interactive Software, Inc. (NASDAQ:TTWO) rating on Thursday, September 14. Robert W. Baird has “Hold” rating and $90.0 target. The rating was maintained by Oppenheimer on Thursday, August 3 with “Buy”. Wedbush maintained Take-Two Interactive Software, Inc. (NASDAQ:TTWO) rating on Thursday, February 4. Wedbush has “Neutral” rating and $30.50 target. The stock of Take-Two Interactive Software, Inc. (NASDAQ:TTWO) has “Neutral” rating given on Wednesday, November 8 by Credit Suisse. The company was maintained on Thursday, September 7 by BMO Capital Markets. The firm earned “Buy” rating on Monday, December 18 by BTIG Research. On Wednesday, June 7 the stock rating was maintained by Piper Jaffray with “Buy”. The firm has “Overweight” rating given on Wednesday, November 8 by Barclays Capital.

Take-Two Interactive Software, Inc. develops, publishes, and markets interactive entertainment solutions for clients worldwide. The company has market cap of $13.38 billion. The firm offers its products under the Rockstar Games and 2K labels. It has a 97.1 P/E ratio. It develops and publishes action/adventure products under the Grand Theft Auto, Max Payne, Midnight Club, and Red Dead names through developing sequels; offering downloadable episodes, and content and virtual currency; and releasing titles for smartphones and tablets.

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. The company has market cap of $140.96 million. The firm is developing Aramchol, an oral therapy, which is in ARREST study, a Phase IIb clinical study for the treatment of patients with overweight or obesity, and who are pre-diabetic or type-II-diabetic with non-alcoholic steato-hepatitis. It currently has negative earnings. It is also evaluating Aramchol through ARRIVE Study, a proof-of-concept Phase IIa clinical trial, with HIV-associated non-alcoholic fatty liver disease and lipodystrophy.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: